Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Direxion Daily LLY Bull 2X Shares (ELIL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: ELIL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 15.91 - 26.62 | Updated Date 04/5/2025 |
52 Weeks Range 15.91 - 26.62 | Updated Date 04/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Direxion Daily LLY Bull 2X Shares
Company Overview
History and Background
The Direxion Daily LLY Bull 2X Shares (symbol LLYU) is an exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, of 200% of the daily performance of the common stock of Eli Lilly and Company (LLY). It was launched to provide investors with a leveraged way to gain short-term exposure to LLY.
Core Business Areas
- Leveraged ETF: LLYU is a leveraged ETF, meaning it aims to amplify the daily returns of its underlying asset (LLY). It is not intended as a buy-and-hold investment and is designed for sophisticated investors with a high risk tolerance.
Leadership and Structure
Direxion is the issuer of LLYU. Their leadership structure involves portfolio managers and investment strategists focused on creating and managing leveraged and inverse ETFs. The specific individuals managing LLYU are not typically publicized.
Top Products and Market Share
Key Offerings
- Direxion Daily LLY Bull 2X Shares (LLYU): This ETF provides 2x leveraged exposure to the daily price movements of Eli Lilly (LLY). Market share data specific to LLYU as a percentage of total ETF assets is not readily available. Competitors include other leveraged healthcare ETFs and individual stock options on LLY.
Market Dynamics
Industry Overview
The ETF market is highly competitive. Leveraged ETFs are a niche within the broader ETF market, typically used for short-term trading strategies. The pharmaceutical sector, which LLYU's underlying asset (LLY) belongs to, is subject to regulatory changes, patent expirations, and drug development risks.
Positioning
LLYU is positioned as a short-term trading tool for investors who are bullish on Eli Lilly and seeking amplified daily returns. Its competitive advantage lies in its leveraged exposure, but this also presents a significant risk to investors.
Total Addressable Market (TAM)
Estimating the TAM specifically for 2x leveraged ETFs on individual stocks is challenging. It's a subset of the overall leveraged ETF market, which is influenced by investor sentiment, market volatility, and interest in the underlying stock (LLY). LLYU captures a portion of this TAM based on investor appetite for LLY exposure.
Upturn SWOT Analysis
Strengths
- Provides leveraged exposure to LLY's daily performance
- Offers potential for high returns in the short term
- Easy to trade on major exchanges
Weaknesses
- High risk due to leverage
- Subject to daily compounding effects, which can erode returns over time
- Not suitable for long-term investment
- High expense ratio compared to non-leveraged ETFs
Opportunities
- Increased investor interest in LLY due to positive drug development news
- Market volatility creating short-term trading opportunities
- Expansion of the leveraged ETF market
Threats
- Negative news or events affecting LLY's stock price
- Changes in regulations affecting leveraged ETFs
- Competition from other leveraged ETFs
- Increased interest rates potentially decreasing investor appetite for high-risk assets
Competitors and Market Share
Key Competitors
- None - LLYU is unique. There are no exact competitors that offer 2x leveraged exposure to LLY specifically. Other leveraged healthcare ETFs exist, such as PILL, but they do not focus solely on LLY.
Competitive Landscape
LLYU's advantage is its specific focus on providing 2x leveraged exposure to LLY. Its disadvantage is its high risk and suitability only for short-term trading.
Growth Trajectory and Initiatives
Historical Growth: LLYU's growth is dictated by the performance of Eli Lilly. Periods of strong growth in LLY's stock price have resulted in corresponding growth in LLYU's NAV.
Future Projections: Future projections for LLYU depend entirely on analysts' expectations for Eli Lilly's stock performance. Given the leverage, volatility is expected to be higher.
Recent Initiatives: Direxion's initiatives primarily focus on managing the ETF's portfolio to maintain the targeted leverage ratio and track the underlying index.
Summary
Direxion Daily LLY Bull 2X Shares (LLYU) is a leveraged ETF designed for short-term, high-risk trading, aiming to amplify the daily returns of Eli Lilly (LLY). Its success is solely dependent on LLY's stock performance and carries considerable risk of loss due to its 2x leverage. While it offers the potential for high returns when LLY is trending upward, investors should be mindful of the compounding effect over time. LLYU is not intended for long-term investment and should be used by sophisticated traders who understand the risks involved.
Peer Comparison
Sources and Disclaimers
Data Sources:
- DirexionShares.com
- SEC Filings
- Yahoo Finance
- Morningstar
Disclaimers:
This analysis is for informational purposes only and does not constitute investment advice. Leveraged ETFs are complex financial instruments and involve significant risk of loss. Investors should consult with a qualified financial advisor before making any investment decisions. Data provided is as of the date of the analysis and may be subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Direxion Daily LLY Bull 2X Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-03-26 | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of LLY and financial instruments, such as swap agreements and options, that, in combination, provide 2X daily leveraged exposure to LLY, consistent with the fund"s investment objective. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.